The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015
The reproducibility of COPD blood eosinophil counts Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018 Year: 2018
Reproducibility of COPD blood eosinophil counts Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018
Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003
Mepolizumab does not alter blood basophil count in severe asthma Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
Blood eosinophil counts in COPD patients compared to controls Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019 Year: 2019
Peripheral eosinophil count as a biomarker for the management of COPD: not there yet Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017 Year: 2017
Determinants of blood eosinophil count in adults from a large population-based study Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
Blood eosinophil count in the general population: typical values and potential confounders Source: Eur Respir J, 55 (5) 1901874; 10.1183/13993003.01874-2019 Year: 2020
Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Automated cell differential count in sputum is feasible and comparable to manual cell count in identifying eosinophilia Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
ERJ October Podcast: blood eosinophil count as a biomarker in patients with airway disease Source: Eur Respir J 2016; 48: E70 Year: 2016
Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD Source: Eur Respir J 2016; 47:1562-1564 Year: 2016
The relation between blood leucocyte count, erythrocyte sedimentation rate, high sensitive C-reactive protein and pulmonary parenchymal infiltration in young male patients with Chlamydia pneumoniae pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017
Elevated baseline blood eosinophil count is related to greater lung function decline over 20-years of follow-up. Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019
Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis Source: Eur Respir J, 59 (1) 2004590; 10.1183/13993003.04590-2020 Year: 2022
Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020